Outcome | Comparison Group, DOTS only (n = 46) | Intervention Group, DOTS + SCI (n = 40) | p-valuea |
---|---|---|---|
 | no. (%) |  | |
End of 2 months | Â | Â | Â |
Treatment interrupted | 4 (8.7%) | 0 (0%) | 0.120 |
Treatment in progress | 42 (91.3%) | 40 (100.0%) | Â |
End of 4 months | Â | Â | Â |
Treatment interrupted | 7 (15.2%) | 1 (2.5) | 0.045 |
Treatment in progress | 39 (84.8%) | 39 (97.5%) | Â |
End of 6 months | Â | Â | Â |
Cured | 16 (34.8%) | 25 (62.5%) | 0.031 |
Treatment completed | 6 (13.0%) | 3 (7.5%) | Â |
Treatment interrupted | 7 (15.2%) | 1 (2.5%) | Â |
Treatment failed | 3 (6.5%) | 0 (0%) | Â |
Treatment in progress | 14 (30.4%) | 11 (27.5%) | Â |
Overall treatment outcome | Â | Â | Â |
Cured | 24 (52.2%) | 32 (80.0%) | 0.019 |
Treatment completed | 12 (26.1%) | 7 (17.5%) | Â |
Treatment interrupted | 7 (15.2%) | 1 (2.5%) | Â |
Treatment failure | 3 (6.5%) | 0 (0%) | Â |